Concepts (82)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Kidney Failure, Chronic | 5 | 2017 | 70 | 1.350 |
Why?
|
| Personal Satisfaction | 3 | 2017 | 31 | 1.150 |
Why?
|
| Renal Replacement Therapy | 2 | 2016 | 8 | 0.590 |
Why?
|
| Quality of Life | 2 | 2017 | 504 | 0.490 |
Why?
|
| Education, Nursing, Baccalaureate | 1 | 2014 | 16 | 0.440 |
Why?
|
| Geriatrics | 1 | 2014 | 47 | 0.430 |
Why?
|
| Transcatheter Aortic Valve Replacement | 1 | 2014 | 57 | 0.420 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2014 | 64 | 0.420 |
Why?
|
| Aortic Valve Stenosis | 1 | 2014 | 85 | 0.420 |
Why?
|
| Postoperative Complications | 1 | 2014 | 631 | 0.320 |
Why?
|
| Renal Dialysis | 3 | 2011 | 53 | 0.260 |
Why?
|
| Creatinine | 1 | 2006 | 59 | 0.250 |
Why?
|
| Homes for the Aged | 1 | 2005 | 7 | 0.240 |
Why?
|
| Health Services for the Aged | 1 | 2005 | 13 | 0.240 |
Why?
|
| Physician's Role | 1 | 2005 | 29 | 0.240 |
Why?
|
| Nursing Homes | 1 | 2005 | 50 | 0.230 |
Why?
|
| Depression | 3 | 2012 | 222 | 0.230 |
Why?
|
| Aged | 8 | 2020 | 5525 | 0.220 |
Why?
|
| Primary Health Care | 1 | 2005 | 160 | 0.210 |
Why?
|
| Virginia | 3 | 2014 | 4 | 0.200 |
Why?
|
| Humans | 12 | 2020 | 28581 | 0.170 |
Why?
|
| Patient Care Team | 2 | 2014 | 66 | 0.170 |
Why?
|
| Polypharmacy | 1 | 2020 | 11 | 0.160 |
Why?
|
| Drug Utilization | 1 | 2020 | 28 | 0.160 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2020 | 67 | 0.150 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2020 | 164 | 0.140 |
Why?
|
| Aged, 80 and over | 3 | 2014 | 2045 | 0.140 |
Why?
|
| Cross-Sectional Studies | 4 | 2020 | 988 | 0.110 |
Why?
|
| Feedback | 1 | 2014 | 33 | 0.110 |
Why?
|
| Students, Nursing | 1 | 2014 | 21 | 0.110 |
Why?
|
| Patient Transfer | 1 | 2014 | 43 | 0.110 |
Why?
|
| Self Concept | 1 | 2014 | 53 | 0.110 |
Why?
|
| Interprofessional Relations | 1 | 2014 | 67 | 0.110 |
Why?
|
| Attitude of Health Personnel | 1 | 2014 | 149 | 0.100 |
Why?
|
| Students, Medical | 1 | 2014 | 102 | 0.100 |
Why?
|
| Male | 7 | 2020 | 13771 | 0.100 |
Why?
|
| Clinical Competence | 1 | 2014 | 234 | 0.100 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2014 | 173 | 0.100 |
Why?
|
| Antidepressive Agents | 1 | 2012 | 29 | 0.100 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2012 | 47 | 0.090 |
Why?
|
| Personality Inventory | 1 | 2011 | 26 | 0.090 |
Why?
|
| Depressive Disorder | 1 | 2011 | 56 | 0.090 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2010 | 98 | 0.080 |
Why?
|
| Geriatric Assessment | 1 | 2010 | 91 | 0.080 |
Why?
|
| Age Factors | 2 | 2010 | 734 | 0.070 |
Why?
|
| Treatment Outcome | 1 | 2014 | 2402 | 0.070 |
Why?
|
| United States | 2 | 2020 | 2201 | 0.070 |
Why?
|
| Tongue Diseases | 1 | 2006 | 2 | 0.060 |
Why?
|
| Acetamides | 1 | 2006 | 3 | 0.060 |
Why?
|
| Oxazolidinones | 1 | 2006 | 4 | 0.060 |
Why?
|
| Kidney Function Tests | 1 | 2006 | 19 | 0.060 |
Why?
|
| Kidney Transplantation | 1 | 2006 | 44 | 0.060 |
Why?
|
| Physician-Nurse Relations | 1 | 2005 | 2 | 0.060 |
Why?
|
| Government Regulation | 1 | 2005 | 13 | 0.060 |
Why?
|
| Body Weight | 1 | 2006 | 250 | 0.060 |
Why?
|
| Anti-Infective Agents | 1 | 2006 | 78 | 0.060 |
Why?
|
| Middle Aged | 3 | 2020 | 7310 | 0.060 |
Why?
|
| Body Mass Index | 1 | 2006 | 405 | 0.060 |
Why?
|
| Female | 5 | 2020 | 15471 | 0.050 |
Why?
|
| Infant | 1 | 2006 | 1019 | 0.050 |
Why?
|
| Child, Preschool | 1 | 2006 | 1167 | 0.050 |
Why?
|
| Psychometrics | 2 | 2011 | 122 | 0.040 |
Why?
|
| Child | 1 | 2006 | 2271 | 0.040 |
Why?
|
| Medicare | 1 | 2020 | 126 | 0.040 |
Why?
|
| Comorbidity | 1 | 2020 | 259 | 0.040 |
Why?
|
| Adolescent | 1 | 2006 | 3165 | 0.040 |
Why?
|
| Prognosis | 1 | 2020 | 807 | 0.030 |
Why?
|
| Adult | 1 | 2006 | 7922 | 0.030 |
Why?
|
| Statistics as Topic | 1 | 2011 | 79 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2011 | 194 | 0.020 |
Why?
|
| Prevalence | 1 | 2012 | 510 | 0.020 |
Why?
|
| Mass Screening | 1 | 2011 | 156 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2012 | 893 | 0.020 |
Why?
|
| Survival Rate | 1 | 2011 | 431 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2010 | 480 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2011 | 782 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2011 | 1026 | 0.020 |
Why?
|
| Linezolid | 1 | 2006 | 4 | 0.020 |
Why?
|
| Immunocompromised Host | 1 | 2006 | 28 | 0.020 |
Why?
|
| Urinary Tract Infections | 1 | 2006 | 39 | 0.020 |
Why?
|
| Risk Factors | 1 | 2011 | 2111 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2012 | 2612 | 0.010 |
Why?
|